跳至主要内容
临床试验/ITMCTR2100004688
ITMCTR2100004688招募中未知

Clinical research of Xinglou Chengqi Decoction on improving post-stroke cognitive impairment due to phlegm heat and viscera excess syndrome based on brain-gut interaction

Wenzhou Integrated Traditional Chinese and Western Medicine Hospital Affiliated to Zhejiang University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 80(—)
性别
All

入选标准

  • 1. The patients met the diagnostic criteria of ischemic stroke in Western medicine.
  • 2. The patients met the diagnostic criteria of vascular cognitive impairment and MMSE score was less than 25.
  • 3. Conformity with the diagnosis of TCM stroke disease name.
  • 4. Within 2 weeks to 6 months from the date of the onset of the disease, the patient has clear consciousness, sufficient visual and auditory abilities, and can cooperate with neuropsychological assessment.
  • 5. Aged 18-85 years (gender without special requirements).
  • 6. Voluntary subjects who sign the informed consent.

排除标准

  • 1. Lacunar infarction,transient ischemic attack.
  • 2. Stroke patients confirmed by examination to be caused by brain tumors, brain trauma, hematological diseases, etc.
  • 3. Patients with cerebral embolism caused by rheumatic heart disease,coronary heart disease and other cardiac diseases combined with atrial fibrillation.
  • 4. Patients with serious primary diseases such as cardiovascular,liver,kidney,hematopoietic and immune systems,or patients with tumors,psychiatric patients,and those without self-knowledge ability.
  • 5. Pregnant and lactating women,allergic constitution.

研究者

发起方
Wenzhou Integrated Traditional Chinese and Western Medicine Hospital Affiliated to Zhejiang University of Traditional Chinese Medicine

相似试验